CHSY3 and neoplasm: To confirm the above findings, qRT-PCR analyses of additional GC patient tumor samples were conducted, revealing CHSY3 to be upregulated in 10 GC tumor samples relative to levels in paired paracancerous samples (Fig. 7A).